Federal Medicare advisers grappled Thursday (Jan. 17) with how CMS could better track opioid use in hospitals and encourage non-opioid alternatives, and it must report to Congress on those issues by March due to a mandate in last year’s landmark opioid bill. Throughout the discussion, Medicare Payment Advisory Commission members and staff identified several obstacles to a comprehensive set of recommendations, including limited data on what hospitals pay for drugs and the amounts they prescribe, concerns about adding burdensome new...